Give Kids a Fighting Chance

Diffuse intrinsic pontine glioma (DIPG) is an aggressive and devastating pediatric cancer with no effecitve treatment options and a 5-year survival rate of less than 1%. In early 2025, children fighting DIPG will have the opportunity to participate in a Phase 1 clinical trial for an innovative new drug that shows potential in treating this deadly form of brain cancer. Donate today to help save lives!  

💖 EMPOWERING GOO

A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE (800-435-7352) WITHIN THE STATE. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE.